XML 68 R32.htm IDEA: XBRL DOCUMENT v3.19.3
EARNINGS PER SHARE/UNIT AND STOCKHOLDERS' EQUITY (Tables)
9 Months Ended
Sep. 30, 2019
EARNINGS PER SHARE/UNIT AND STOCKHOLDERS' EQUITY [Abstract]  
Calculation of Earnings Per Share/Unit

 

Successor

 

 

Predecessor

 

Three Months

 

Nine Months

 

Three Months

 

Four Months

 

 

Five Months

 

Ended

 

Ended

 

Ended

 

Ended

 

 

Ended

 

September 30,

 

September 30,

 

September 30,

 

September 30,

 

 

May 31,

 

2019

  

2019

 

2018

 

2018

 

  

2018

Net loss attributable to Successor/

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Predecessor

$

(19,529)

 

$

(116,211)

 

$

(9,760)

 

$

(10,298)

 

 

$

(610,525)

Predecessor’s general partner’s 2%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

interest in net loss

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 

12,211

Net loss available to common

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

stockholders/limited partners

$

(19,529)

 

$

(116,211)

 

$

(9,760)

 

$

(10,298)

 

 

$

(598,314)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares/units

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

10,131

 

 

10,080

 

 

10,028

 

 

10,021

 

 

 

49,369

Dilutive effect of potential common shares/units

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 

 —

Diluted

 

10,131

 

 

10,080

 

 

10,028

 

 

10,021

 

 

 

49,369

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net earnings per share/unit:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

$

(1.93)

 

$

(11.53)

 

$

(0.97)

 

$

(1.03)

 

 

$

(12.12)

Diluted

$

(1.93)

 

$

(11.53)

 

$

(0.97)

 

$

(1.03)

 

 

$

(12.12)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Antidilutive restricted stock shares (1)

 

169,600

 

 

169,600

 

 

 —

 

 

 —

 

 

 

 —

Antidilutive warrants (2)

 

800,000

 

 

800,000

 

 

800,000

 

 

800,000

 

 

 

 —


(1)

Amount represents unvested restricted stock shares as of the end of the period that are excluded from the diluted net earnings per share calculations because of their antidilutive effect.

 

(2)

Amount represents warrants to purchase 800,000 shares of the Company’s common stock at a per share exercise price of $37.48 that are excluded from the diluted net earnings per share calculations because of their antidilutive effect.